Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
The DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index.
Abstract
The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders. Small intermediates - soluble oligomers - in the aggregation process can confer synaptic dysfunction, whereas large, insoluble deposits might function as reservoirs of the bioactive oligomers. These emerging concepts are exemplified by Alzheimer's disease, in which amyloid beta-protein oligomers adversely affect synaptic structure and plasticity. Findings in other neurodegenerative diseases indicate that a broadly similar process of neuronal dysfunction is induced by diffusible oligomers of misfolded proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This observation suggests that oligodendrocytes could potentially generate a relatively higher proportion of longer Aβ species, which are more prone to aggregation [28]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“The increased Aβ 42:40 ratio in oligodendrocytes could contribute to the high proportion of soluble aggregates [28,42,43]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“and, consequently, could be more pathogenic than shorter Aβ species”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“However, recent in vivo studies have shown that soluble Aβ oligomers are more neurotoxic than amyloid plaques and most likely responsible for synaptic dysfunction and memory loss in AD.7–11”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [8]
In the citing paper
“Dysregulation of A peptide metabolism is hypothesized to initiate pathogenic cascades that lead to Alzheimer's disease (AD) (Haass and Selkoe, 2007).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Haass and Selkoe, 2007
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Self-citationSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“These and other findings led to the formal proposal of a hypothesis of disease in which excessive Aβ accumulation and deposition could trigger a complex downstream cascade that resulted in the symptoms of A”
ResultRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“In a similar manner, breakthrough discoveries of causative genes allowed the subsequent identification of aggregation-prone proteins in disorders such as amyotrophic lateral sclerosis (ALS”
ResultUbiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 1×
“More recently, TDP43 was found to be deposited in tau- and synuclein-negative inclusions in a disorder designated as frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) as well as in AL”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Shortly thereafter, a distinct APP missense mutation was found in a family with early-onset A”
Background
Cited by
Items 901–1,000 of 1,119
Tau, prions and Aβ: the triad of neurodegeneration
Reiniger, L., Lukić, A., Linehan, J. M., Rudge, P., Collinge, J., Mead, S., & Brandner, S. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0691-0 · Cited by 102
“The current version assumes a toxic role of soluble prefibrillar oligomers based on the several in vivo and in vitro experiments [37, 42 ].”
BackgroundThe interaction of beta-amyloid protein with cellular membranes stimulates its own production
Peters, I., Igbavboa, U., Schütt, T., Haidari, S., Hartig, U., Rosello, X., Böttner, S., Copanaki, E., Deller, T., Kögel, D., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.01.012 · Cited by 90
“Current research suggests that oligomeric forms of Aβ may play a major role in AD pathophysiology [3, 4].”
Lee, L., Sakurai, M., Matsuzaki, S., Arancio, O., & Fraser, P. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8257-7 · Cited by 91
“The numerous detrimental effects observed in these studies include internalization of glutamate receptors, altered neurotransmitter release and uptake, and deficits in synaptic plasticity (Li et al. 2009; Haass and Selkoe 2007; Holtzman et al. 2011b; Mucke and Selkoe 2012).”
BackgroundInfluentialSolid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid β-protein fibrils
Masuda, Y., Fukuchi, M., Yatagawa, T., Tada, M., Takeda, K., Irie, K., Akagi, K., Monobe, Y., Imazawa, T., & Takegoshi, K. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.08.052 · Cited by 99
Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease
Lee, L., Dale, E., Staniszewski, A., Zhang, H., Saeed, F., Sakurai, M., Fà, M., Orozco, I. J., Michelassi, F. E., Akpan, N., et al. (2014) · Scientific Reports · doi:10.1038/srep07190 · Cited by 102
Close association of water channel AQP1 with amyloid-β deposition in Alzheimer disease brains
Misawa, T., Arima, K., Mizusawa, H., & Satoh, J.-I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0387-x · Cited by 90
“Because intracerebral accumulation of amyloid- (A) plays a central role in the pathogenesis of AD [ 16 ], and activated astrocytes are often associated with A plaques in AD brains [37, 55], we investigated the possible relationship between A deposition and AQP1 expression in astrocytes in the cerebral cortex of AD. Ma…”
BackgroundCopper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic
Kepp, K. P., & Squitti, R. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.06.018 · Cited by 96
Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants
Wang, S. S. ‐., Liu, K.-N., & Han, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.02.008 · Cited by 90
Sipos, E., Kurunczi, A., Kasza, Á., Horváth, J., Felszeghy, K., Laroche, S., Toldi, J., Párducz, Á., Penke, B., & Penke, Z. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.011 · Cited by 98
Beclin 1 Complex in Autophagy and Alzheimer Disease
Jaeger, P. A., & Wyss-Coray, T. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.258 · Cited by 90
“It exists in monomeric, oligomeric, and fibrillar form and has been implicated as a neurotoxic agent inside as well as outside the cell.(2,3) More recently, other cleavage products of APP have been identified as possible players in AD pathology as well.”
BackgroundCharacterization of the Interaction of β-Amyloid with Transthyretin Monomers and Tetramers
Du, J., & Murphy, R. M. (2010) · Biochemistry · doi:10.1021/bi101280t · Cited by 104
“Multiple studies indicate that toxicity arises early, and is attributable to soluble Aβ oligomers and/or protofibrils (6,7).”
BackgroundZempel, H., & Mandelkow, E.-M. (2012) · Neurodegenerative Diseases · doi:10.1159/000332816 · Cited by 90
Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations
Tian, H., Davidowitz, E., Lopez, P., Emadi, S., Moe, J., & Sierks, M. (2013) · International Journal of Cell Biology · doi:10.1155/2013/260787 · Cited by 90
“Hindawi Publishing Corporation International Journal of Cell Biology Volume 2013, Article ID 260787, 9 pages http://dx.doi.org/10.1155/2013/260787”
BackgroundInfluentialLow‐n oligomers as therapeutic targets of Alzheimer’s disease
Ono, K., & Yamada, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07187.x · Cited by 76
“…evidence supports the hypothesis that Ab oligomers play a seminal role in AD (Kirkitadze et al. 2002; Walsh et al. 2002; Wang et al. 2002; Klein et al. 2004; McLaurin et al. 2006; Cheng et al. 2007; Haass and Selkoe 2007; Walsh and Selkoe 2007; Shankar et al. 2008; Roychaudhuri et al. 2009).”
BackgroundResultAmyloid-β-induced Synapse Damage Is Mediated via Cross-linkage of Cellular Prion Proteins
Bate, C., & Williams, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248724 · Cited by 89
Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
The Parkinson Study Group DATATOP Investigators, Zhang, J., Mattison, H. A., Liu, C., Ginghina, C., Auinger, P., McDermott, M. P., Stewart, T., Kang, U. J., Cain, K. C., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1121-x · Cited by 89
“Changes in the levels of CSF Aβ42 are not well understood, but their decreases observed in AD are conventionally thought to arise by the aggregation and deposition of Aβ42 in neuritic plaques or trapped in brain parenchyma as soluble or insoluble oligomers [15, 37, 55].”
Sharma, S., Verma, S., Kapoor, M., Saini, A., & Nehru, B. (2016) · Neurological Research · doi:10.1080/01616412.2016.1209337 · Cited by 89
Essential Oils as Treatment Strategy for Alzheimerʼs Disease: Current and Future Perspectives
Benny, A., & Thomas, J. (2018) · Planta Medica · doi:10.1055/a-0758-0188 · Cited by 92
“Senile plaques and neurofibrillary tangles (NFTs) comprised of amyloid β (A β ) peptides and hyper-phosphorylated tau proteins, respectively, are the classic pathological hallmarks of AD [1].”
Umar, T., Shalini, S., Raza, M. K., Gusain, S., Kumar, J., Seth, P., Tiwari, M., & Hoda, N. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.038 · Cited by 94
Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice
Tóth, M. E., Szegedi, V., Varga, E., Juhász, G., Horváth, J., Borbély, E., Csibrány, B., Alföldi, R., Lénárt, N., Penke, B., et al. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0428-9 · Cited by 106
D-amino acid-containing supramolecular nanofibers for potential cancer therapeutics
Wang, H., Feng, Z., & Xu, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.008 · Cited by 90
Amyloid-β Oligomers May Impair SNARE-Mediated Exocytosis by Direct Binding to Syntaxin 1a
Yang, Y., Kim, J., Kim, H. Y., Ryoo, N., Lee, S., Kim, Y., Rhim, H., & Shin, Y.-K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.044 · Cited by 88
“…are strongly suspected to influence the progression of AD, diverse pathological roles of the aggregated protein in the synapse have been reported (Benilova et al., 2012; Haass and Selkoe, 2007; Hardy, 2009; LaFerla et al., 1995; McLean et al., 1999; Puzzo et al., 2008; Shankar et al., 2008).”
BackgroundJürgensen, S., Antonio, L. L., Mussi, G. E. A., Brito-Moreira, J., Bomfim, T. R., De Felice, F. G., Garrido-Sanabria, E. R., Cavalheiro, É. A., & Ferreira, S. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177790 · Cited by 88
Novel γ-Secretase Enzyme Modulators Directly Target Presenilin Protein
Ebke, A., Luebbers, T., Fukumori, A., Shirotani, K., Haass, C., Baumann, K., & Steiner, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.276972 · Cited by 88
Self-citationBraymer, J. J., Choi, J.-S., DeToma, A. S., Wang, C., Nam, K., Kampf, J. W., Ramamoorthy, A., & Lim, M. H. (2011) · Inorganic Chemistry · doi:10.1021/ic2012205 · Cited by 87
Frizzled‐1 is involved in the neuroprotective effect of Wnt3a against Aβ oligomers
Chacón, M. A., Varela‐Nallar, L., & Inestrosa, N. C. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21497 · Cited by 87
“Since the main toxic species derived from Ab peptide are the oligomers (Lacor et al., 2004; Cleary et al., 2005; Haass and Selkoe, 2007), we analyzed the toxicity of Ab oligomers in PC12 cells and evaluated the potential protective role of Wnt3a.”
BackgroundVenkataramani, V., Doeppner, T. R., Willkommen, D., Cahill, C. M., Xin, Y., Ye, G., Liu, Y., Southon, A. G., Aron, A. T., Au‐Yeung, H. Y., et al. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14580 · Cited by 86
Oligomeric Cucurbituril Complexes: from Peculiar Assemblies to Emerging Applications
Yang, X., Wang, R., Kermagoret, A., & Bardelang, D. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004622 · Cited by 88
Chhimpa, N., Singh, N., Puri, N., & Kayath, H. P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220514 · Cited by 94
“rotoxicity [177] by numerous mechanisms like the”
Ceccom, J., Coslédan, F., Halley, H., Francès, B., Lassalle, J. M., & Meunier, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043105 · Cited by 88
The missing link in the amyloid cascade of Alzheimer’s disease – Metal ions
Tiiman, A., Palumaa, P., & Tõugu, V. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.023 · Cited by 104
“The c-secretase cuts the APP at several different positions and the resulting Ab peptides have different lengths (major forms being Ab40 80–90% and Ab42 5–10%) (DeToma et al., 2012; Haass and Selkoe, 2007; Jakob-Roetne and Jacobsen, 2009).”
Zhao, G., Liu, Z., Ilagan, M. X. G., & Kopan, R. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3826-09.2010 · Cited by 88
“…-secretase activity cleave APP, it can proceed from the -cleavage site to the -cleavage site, a hallmark of -secretase (Tanzi and Bertram, 2005; Haass and Selkoe, 2007), even in the absence of NCT. -Secretase-like activity in NCT / cells is PS1 dependent The fact that two unrelated -secretase…”
Rahimi, F., Shanmugam, A., & Bitan, G. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533358 · Cited by 88
“Global research efforts have established a framework for understanding the fundamentals of Aβ assembly [7,10,11].”
BackgroundKim, S. H., Fraser, P. E., Westaway, D., St. George-Hyslop, P. H., Ehrlich, M. E., & Gandy, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4717-09.2010 · Cited by 88
“Curiously, low picomolar levels of A 42 can actually enhance LTP (Puzzo et al., 2008), suggesting that precisely controlled production and release of A 42 from the synapse is likely to play an important role in regulation of synaptic plasticity.”
BackgroundGizaw, S. T., Ohashi, T., Tanaka, M., Hinou, H., & Nishimura, S. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.03.009 · Cited by 89
“, Aß and α-synuclein) have also been implicated as the primary toxic species in many degenerative diseases [8].”
BackgroundThe Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease
Walker, L. C., Schelle, J., & Jucker, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024398 · Cited by 103
D’Souza, Y., Elharram, A., Soon-Shiong, R., Andrew, R. D., & Bennett, B. M. (2015) · Molecular Brain · doi:10.1186/s13041-015-0117-y · Cited by 87
“Oligomeric Aβ assemblies are known to induce neurotoxicity in vitro and in vivo [42-44], and both soluble Aβ and oAβ correlate with disease progression in AD patients [45-47].”
BackgroundCholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease
Yakel, J. L. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1200-1 · Cited by 87
“It should be noted that while rodent models have been very useful in helping to understand the cholinergic system and that there is a high degree of sequence homology between human and rodent nAChRs, even small numbers of amino acid differences have been shown to alter functional properties of these receptors, and the…”
Mosconi, L., Murray, J., Davies, M., Williams, S., Pirraglia, E., Spector, N., Tsui, W. H., Li, Y., Butler, T., Osorio, R. S., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004850 · Cited by 87
“Nutrients may have an impact on Aβ oligomers, which are not detectable with PiB-PET, prior to plaque formation.(68) A low saturated fat/glycaemic index diet was shown to improve Aβ composition in cerebrospinal fluid in MCI,(69) suggesting that diet is a powerful environmental factor that modulates AD risk through its…”
BackgroundCurrent and future treatment of amyloid diseases
Ankarcrona, M., Winblad, B. G., Monteiro, C., Fearns, C., Powers, E. T., Johansson, J., Westermark, G. T., Presto, J., Ericzon, B. ‐., & Kelly, J. W. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12506 · Cited by 99
Role of miRNAs in development and disease: Lessons learnt from small organisms
Chandra, S., Vimal, D., Sharma, D., Rai, V., Gupta, S. C., & Chowdhuri, D. K. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.017 · Cited by 95
Kaya, I., Zetterberg, H., Blennow, K., & Hanrieder, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00121 · Cited by 91
Thal, D. R., & Tomé, S. O. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.006 · Cited by 84
Wang, F., Zhang, Y., Wang, L., Sun, P., Luo, X., Ishigaki, Y., Sugai, T., Yamamoto, R., & Kato, N. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.027 · Cited by 89
“…model mice (Cramer et al., 2012), soluble Ab has also been a focus of attention as a key to link cognitive dysfunction and underlying molecular events in AD pathogenesis (Hardy and Selkoe, 2002; Kamenetz et al., 2003; Haass and Selkoe, 2007; Brody and Holtzman, 2008), especially at its early phase.”
Cerebrovascular disorders: molecular insights and therapeutic opportunities
Storkebaum, E., Quaegebeur, A., Vikkula, M., & Carmeliet, P. (2011) · Nature Neuroscience · doi:10.1038/nn.2947 · Cited by 96
Kumar, S., Tepper, K., Kaniyappan, S., Biernat, J., Wegmann, S., Mandelkow, E.-M., Müller, D. J., & Mandelkow, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554725 · Cited by 87
“Soluble prefibrillary protein aggregates or “oligomers,” rather than insoluble aggregated proteins, appear to be the most toxic species responsible for cell dysfunction and death (5).”
BackgroundSpike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change
Dolev, I., Fogel, H., Milshtein-Parush, H., Berdichevsky, Y., Lipstein, N., Brose, N., Gazit, N., & Slutsky, I. (2013) · Nature Neuroscience · doi:10.1038/nn.3376 · Cited by 97
Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97
Protein N-homocysteinylation: From cellular toxicity to neurodegeneration
Sharma, G. S., Kumar, T., Dar, T. A., & Singh, L. R. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.08.013 · Cited by 93
Jang, H., Arce, F. T., Ramachandran, S., Kagan, B. L., Lal, R., & Nussinov, R. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60459d · Cited by 92
Ahyayauch, H., Raab, M., Busto, J. V., Andraka, N., Arrondo, J.-L. R., Masserini, M., Tvaroška, I., & Goñi, F. M. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.06.043 · Cited by 90
Spencer, R. K., Li, H., & Nowick, J. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5017409 · Cited by 88
Mammalian phospholipase D: Function, and therapeutics
McDermott, M. I., Wang, Y., Wakelam, M. J. O., & Bankaitis, V. A. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.101018 · Cited by 93
Oligodendrocytes in Alzheimer’s disease pathophysiology
Kedia, S., & Simons, M. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01873-x · Cited by 86
Miyamae, Y., Kurisu, M., Murakami, K., Han, J., Isoda, H., Irie, K., & Shigemori, H. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.08.001 · Cited by 97
Forrest, C. M., Mackay, G. M., Stoy, N., Spiden, S. L., Taylor, R., Stone, T. W., & Darlington, L. G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06442.x · Cited by 85
Amyloid in neurodegenerative diseases: Friend or foe?
Wolfe, K. J., & Cyr, D. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.03.011 · Cited by 93
“Amyloid aggregation in AD occurs with cleavage of APP fragment into Aβ42 which accumulates in extracellular amyloid plaques [27].”
BackgroundAttanasio, F., Convertino, M., Magno, A., Caflisch, A., Corazza, A., Haridas, H., Esposito, G., Cataldo, S., Pignataro, B., Milardi, D., et al. (2013) · ChemBioChem · doi:10.1002/cbic.201200704 · Cited by 85
Dislich, B., Wohlrab, F., Bachhuber, T., Müller, S. A., Kuhn, P.-H., Hogl, S., Meyer-Luehmann, M., & Lichtenthaler, S. F. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.041533 · Cited by 85
“It is the rate-limiting enzyme in a proteolytic cascade leading to the liberation of the neurotoxic A peptide from the much larger amyloid precursor protein (APP) into the extracellular space (8, 9).”
BackgroundAmino Acid Position-specific Contributions to Amyloid β-Protein Oligomerization
Maji, S. K., Ogorzalek Loo, R. R., Inayathullah, M., Spring, S. M., Vollers, S. S., Condron, M. M., Bitan, G., Loo, J. A., & Teplow, D. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038133 · Cited by 86
Combined Effects of Agitation, Macromolecular Crowding, and Interfaces on Amyloidogenesis
Lee, C. F., Bird, S. H., Shaw, M. K., Jean, L., & Vaux, D. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400580 · Cited by 87
“The identity of the toxic species remains controversial but an increasing body of evidence suggests that soluble oligomers cause cell dysfunction and death in amultitude of ways (1, 2).”
BackgroundPathogenesis of Abeta Oligomers in Synaptic Failure
Sivanesan, S., Tan, A., & Rajadas, J. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310030011 · Cited by 86
“Therefore it is highly evident from several studies [13, 45, 52] that the soluble A oligomers can inhibit LTP in AD brains to increase synaptic failure, whereas large, insoluble deposits are the reservoirs for accumulating amyloids [53].”
BackgroundBrody, A. H., & Strittmatter, S. M. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.09.007 · Cited by 86
“It is widely believed that these autosomal dominant mutations lead to an amyloidogenic shift in the cleavage of APP resulting in the favored generation of the Aβ42 isoform over the smaller, less hydrophobic Aβ40 isoform (reviewed by Haass & Selkoe, 2007).”
BackgroundResultInfluentialLeuner, K., Stockburger, C., Denzer, I., Eckert, G. P., & Müller, W. E. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00007-6 · Cited by 94
Naturally occurring polyphenolic inhibitors of amyloid beta aggregation
Churches, Q. I., Caine, J. M., Cavanagh, K., Epa, V. C., Waddington, L. J., Tranberg, C. E., Meyer, A. G., Varghese, J. N., Streltsov, V. A., & Duggan, P. J. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.008 · Cited by 90
Review: Modulating the unfolded protein response to prevent neurodegeneration and enhance memory
Halliday, M., & Mallucci, G. R. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12211 · Cited by 84
Molecular subtypes of Alzheimer’s disease
Fede, G. D., Catania, M., Maderna, E., Ghidoni, R., Benussi, L., Tonoli, E., Giaccone, G., Moda, F., Paterlini, A., Campagnani, I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21641-1 · Cited by 97
Walker, L. C. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3025 · Cited by 171
“The relationship between Aβ-oligomers and the diverse plaque types [31, 33, 38] in the human brain - e.”
BackgroundAgostinho, P., Pliássova, A., Oliveira, C. R., & Cunha, R. A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142730 · Cited by 85
“[22, 23].”
Vieira, M. N. N., Forny‐Germano, L., Saraiva, L. M., Sebollela, A., Martinez, A. M. B., Houzel, J., De Felice, F. G., & Ferreira, S. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04809.x · Cited by 85
“We used primary cortical neurons as a model because amyloid oligomers from different proteins appear to be causatively related to several neurodegenerative disorders (Klein 2006; Ferreira et al. 2007; Haass and Selkoe 2007 ).”
BackgroundMethodInfluentialCurcuminoid Binds to Amyloid-β1-42 Oligomer and Fibril
Yanagisawa, D., Taguchi, H., Yamamoto, A., Shirai, N., Hirao, K., & Tooyama, I. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-102100 · Cited by 85
“However, the correlation between A deposition and dementia in AD is not well understood [5].”
Santos, D. B., Peres, K. C., Ribeiro, R. P., Colle, D., dos Santos, A. A., Moreira, E. L. G., Souza, D. O., Figueiredo, C. P., & Farina, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.036 · Cited by 96
Amyloid-β Oligomers Induce Differential Gene Expression in Adult Human Brain Slices
Sebollela, A., Freitas-Correa, L., Oliveira, F. F., Paula-Lima, A. C., Saraiva, L. M., Martins, S. M., Mota, L. D., Torres, C., Alves-Leon, S., de Souza, J. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298471 · Cited by 85
Valensin, D., Anzini, P., Gaggelli, E., Gaggelli, N., Tamasi, G., Cini, R., Gabbiani, C., Michelucci, E., Messori, L., Kozłowski, H., et al. (2010) · Inorganic Chemistry · doi:10.1021/ic902593e · Cited by 92
Soluble Prion Protein Inhibits Amyloid-β (Aβ) Fibrillization and Toxicity
Nieznański, K., Choi, J.-K., Chen, S., Surewicz, K. A., & Surewicz, W. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.400614 · Cited by 91
Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β
Park, H., Kam, T.-I., Kim, Y., Choi, H., Gwon, Y., Kim, C., Koh, J.-Y., & Jung, Y.-K. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds100 · Cited by 85
“Ab is derived from the amyloid precursor protein cleaved by b- and g-secretases (4).”
Druggability of Intrinsically Disordered Proteins
Joshi, P., & Vendruscolo, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-20164-1_13 · Cited by 86
“The aggregation of the Aβ peptide into oligomeric assemblies and ordered fibrils is associated with Alzheimer’s disease (Chiti and Dobson 2006; Haass and Selkoe 2007; Knowles et al. 2014).”
BackgroundKaludercic, N., & Giorgio, V. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3869610 · Cited by 96
Kell, D., & Pretorius, E. (2017) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.08.006 · Cited by 85
Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry
Sciacca, M. F. M., Romanucci, V., Zarrelli, A., Monaco, I., Lolicato, F., Spinella, N., Galati, C., Grasso, G., D’Urso, L., Romeo, M., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00110 · Cited by 92
Bunce, S. J., Wang, Y., Stewart, K. L., Ashcroft, A. E., Radford, S. E., Hall, C. K., & Wilson, A. J. (2019) · Science Advances · doi:10.1126/sciadv.aav8216 · Cited by 85
“Wolynes, Exploring the aggregation free energy landscape of the amyloid- protein (1-40).”
Proteostasis impairment in ALS
Ruegsegger, C., & Saxena, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.032 · Cited by 95
Amyloid β‐induced astrogliosis is mediated by β1‐integrin via NADPH oxidase 2 in Alzheimer's disease
Wyssenbach, A., Quintela, T., Llavero, F., Zugaza, J. L., Matute, C., & Alberdi, E. (2016) · Aging Cell · doi:10.1111/acel.12521 · Cited by 82
“Amyloid-b (Ab) species and their accumulation in plaques are key steps in the pathogenesis of AD (Haass & Selkoe, 2007).”
BackgroundAmphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders
Rakotoarisoa, M., & Angelova, A. (2018) · Medicines · doi:10.3390/medicines5040126 · Cited by 82
Hoshino, T., Mahmood, M. I., Mori, K., & Matsuzaki, K. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4029062 · Cited by 84
Jiang, P., Li, W., Shea, J., & Mu, Y. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.02.010 · Cited by 96
Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro
Horiuchi, M., Maezawa, I., Itoh, A., Wakayama, K., Jin, L.-W., Itoh, T., & DeCarli, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.007 · Cited by 84
“Although amyloid (A ) protein aggregation is posited to be the pathologic first step of the AD process (Haass and Selkoe, 2007), A protein can lso be found in relatively high concentration in cerebral hite matter (Roher et al., 2002).”
BackgroundBrito-Moreira, J., Lourenco, M. V., Oliveira, M. M., Ribeiro, F. C., Ledo, J. H., Diniz, L. P., Vital, J. F. S., Magdesian, M. H., Melo, H. M., Barros-Aragão, F., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.761189 · Cited by 84
Bhattacharyya, R., Black, S. E., Lotlikar, M. S., Fenn, R. H., Jorfi, M., Kovacs, D. M., & Tanzi, R. E. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109134 · Cited by 84
“Synaptic dysfunction, preceded by reduced synaptic transmission and loss of dendritic spines, is largely driven by neurotoxic A β 42 -oligomers (Cleary et al., 2005; Haass and Selkoe, 2007).”
Molecular basis of β-amyloid oligomer recognition with a conformational antibody fragment
Morgado, I., Wieligmann, K., Bereza, M., Rönicke, R., Meinhardt, K., Annamalai, K., Baumann, M., Wacker, J., Hortschansky, P., Malešević, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206433109 · Cited by 80
“T self-assembly of β-amyloid (Aβ) peptide into mature, β-sheet–rich, amyloid fibrils represents a fundamental event of Alzheimer’s disease (AD) (1, 2).”
BackgroundInfluentialMicroglia and Synapse: Interactions in Health and Neurodegeneration
Šišková, Z., & Tremblay, M.-È. (2013) · Neural Plasticity · doi:10.1155/2013/425845 · Cited by 80
“While neuronal death is the final, irreversible outcome in such diseases, the loss of synapses has emerged as a major correlate of cognitive decline [46].”
Collins-Praino, L. E., Francis, Y. I., Griffith, E. Y., Wiegman, A. F., Urbach, J., Lawton, A., Honig, L. S., Cortes, E., Vonsattel, J. P. G., Canoll, P. D., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0083-0 · Cited by 79
“Given the growing body of evidence that it is the levels of soluble Aβ oligomers, rather than insoluble Aβ fibrils, that correlate with the extent of synaptic loss and the severity of cognitive impairment in AD [38,39,43], however, future studies should also investigate the correlation between cortical and white matte…”
BackgroundAPP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79
“Apart from the differences in highly aggregated insoluble Ab structures, some comparison is necessary in view of the emerging role of soluble Ab oligomers, currently considered the most intriguing species responsible for both synaptic dysfunction and memory loss (Haass and Selkoe 2007; Selkoe 2008).”
Röhr, D., Boon, B. D. C., Schuler, M., Kremer, K., Hoozemans, J. J. M., Bouwman, F. H., El-Mashtoly, S. F., Nabers, A., Großerueschkamp, F., Rozemuller, A. J. M., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01091-5 · Cited by 77
“The most accepted hypothesis for AD pathogenesis is the amyloid cascade hypothesis [32, 66].”
BackgroundSchönherr, C., Bien, J., Isbert, S., Wichert, R., Prox, J., Altmeppen, H., Kumar, S., Walter, J., Lichtenthaler, S. F., Weggen, S., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0084-5 · Cited by 76
“are key events in the pathogenesis of AD [10, 33].”
Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease
Schmidt, V., Baum, K., Lao, A., Rateitschak, K., Schmitz, Y., Teichmann, A., Wiesner, B., Petersen, C. M., Nykjaer, A., Wolf, J., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.352 · Cited by 75
“According to the amyloid hypothesis, the extent of proteolytic processing of the amyloid precursor protein (APP) into amyloid-b (A b ) peptides is central to the pathology of Alzheimer’s disease (AD) (Haass and Selkoe, 2007).”
Roy, B., & Jackson, G. R. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu011 · Cited by 75
Arnsten, A. F. T., Datta, D., Leslie, S., Yang, S.-T., Wang, M., & Nairn, A. C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903671116 · Cited by 74
Caetano, F. A., Beraldo, F. H., Hajj, G. N. M., Guimaraes, A. L., Jürgensen, S., Wasilewska-Sampaio, A. P., Hirata, P. H. F., Souza, I., Machado, C. F., Wong, D. Y.-L., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07225.x · Cited by 74
Iacono, D., Resnick, S. M., O’Brien, R., Zonderman, A. B., An, Y., Pletnikova, O., Rudow, G., Crain, B., & Troncoso, J. C. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000052 · Cited by 73
“Apart from a differential level of soluble AA or tau oligomers (27, 28), inflammatory reaction may also account for this difference (29).”
Metadata
- Authors
- Haass, C., & Selkoe, D. J.
- Affiliations
- Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie (DE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2007-02
- Volume
- 8
- Issue
- 2
- Pages
- 101-112
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1980825524
- Cited by
- 4,744
- References
- 135
- Citations by year
- 2026: 135 · 2025: 171 · 2024: 165 · 2023: 170 · 2022: 195 · 2021: 239 · 2020: 273 · 2019: 247 · 2018: 276 · 2017: 290 · 2016: 331 · 2015: 313 · 2014: 285 · 2013: 307 · 2012: 327
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, neurodegeneration, protein misfolding, protein aggregation, synaptic dysfunction, synaptic plasticity, Parkinson's disease, Huntington's disease, prion disease, neuronal dysfunction
- MeSH terms
- Alzheimer Disease, Cell Membrane, Humans, Memory Disorders, Models, Biological, Nerve Degeneration, Solubility, Synapses, Signal Transduction, Amyloid beta-Peptides, Protein Folding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.